Request Appointment Patient Portal Telemedicine Consent Physician Referrals Research Referrals
  • facebook.pngfacebook.png
  • twitter.pngtwitter.png
  • linkedin.pnglinkedin.png
Texas Liver Institute
  • Home
  • About
    • Research
    • Austin Clinic
    • Dallas Clinic
    • Vision & Mission
    • Physicians & Providers
    • Affiliations
    • Events
    • Disclosures
  • Services
    • Clinical Services
    • Nutrition Information
  • Education
    • About Your Liver
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C (HCV)
    • Chronic Hepatitis C
    • Autoimmune Hepatitis
    • Cirrhosis
    • Fatty Liver Disease
    • Liver Cancer
    • Hemochromatosis
    • Hepatocellular Carcinoma (HCC)
    • Primary Biliary Cholangitis (PBC)
    • Primary Sclerosing Cholangitis (PSC)
    • Health and Wellness
  • Research Studies
  • Patient Resources
    • Patient Portal
    • Telemedicine Consent
    • What to Bring to Your Appointment
    • What to Expect During Your Visit
    • Working with Your Insurance
    • Our Financial Policies
    • Understanding Your Bill
    • Privacy Policy and HIPAA
    • FAQs
    • Patient Forms
  • Liver Updates
    • Liver News
    • Newsletters
    • Video Lectures
    • Slide Presentations
    • Most Recent Publications
  • Contact
    • Contact Us
    • Request Appointment!
    • Physican Referrals
    • Careers

May 05 2015

Hepatitis C: Interferon’s Return Stirs Controversy

Sean Hendrickson

Media

The use of interferon to treat hepatitis C infections has fallen out of favor...

Read More

May 05 2015

C-SWIFT: 8 weeks of therapy may be possible with grazoprevir/elbasvir

Sean Hendrickson

Media

VIENNA — Patients with cirrhosis as well as genotype 1 and genotype 3 HCV...

Read More

May 05 2015

Previous treatment failures respond to 24 weeks of Harvoni

Sean Hendrickson

Media

VIENNA — Twenty-four weeks of treatment with Harvoni yielded a 12-week sustained virologic response...

Read More

May 05 2015

HSC NEWS – Study shows promising results for curing hard-to-treat hepatitis C in patients awaiting or completing liver transplant

Sean Hendrickson

Media

UT Health Science Center San Antonio doctor presents results of daclatasvir regimen SAN ANTONIO...

Read More

May 01 2015

Merck says experimental Hepatitis C treatment shows 95% cure rate – MarketWatch

Sean Hendrickson

Media

Merck & Co. said Friday that its experimental drug combination for treating chronic hepatitis...

Read More

May 01 2015

Study results promising for hepatitis C patients awaiting or completing liver transplant

Sean Hendrickson

Media

A number of new, highly effective oral treatments for various types of hepatitis C...

Read More

Feb 01 2015

Gastroenterology & Endoscopy News – Shorter Hepatitis C Treatment Durations May Be a Reality

Sean Hendrickson

Media

Boston—Can treatment of hepatitis C infection with new direct-acting antivirals (DAAs) be shortened to...

Read More

Jan 10 2015

Advances in Chronic Hepatitis C Management and Treatment

Sean Hendrickson

Media

Following this program, participants should be better able to: Use in a clinical setting important...

Read More

Dec 31 2014

Beclabuvir with PEG-IFN a-2a/ribavirin safely treated HCV

Sean Hendrickson

Media

In a phase 2a clinical trial, treatment with beclabuvir and a combination of pegylated...

Read More

Dec 19 2014

FDA Approves AbbVie’s Hepatitis Treatment

Sean Hendrickson

Media

Multidrug Regimen Seen Challenging Recently Approved Drugs from Gilead Sciences U.S. regulators on Friday...

Read More
Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Next
San Antonio

607 Camden St
Suite 101
San Antonio, Texas 78215

Phone : 210-253-3426

Fax : 210-227-6951

Austin

7940 Shoal Creek Blvd
Suite 205
Austin, Texas 78757

Phone : 512-454-8378

Fax : 512-454-8375

Dallas

7515 Greenville Ave
Suite 600
Dallas, Texas 75231

Phone : 214-945-2521

Fax : 214-945-2524

Patient Education

  • About Your Liver
  • Hepatitis
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C (HCV)
    • Chronic Hepatitis C
    • Autoimmune Hepatitis
  • Fatty Liver Disease
  • Liver Cancer
  • Cirrhosis
  • Hemochromatosis
  • PBC/PSC

Appointments

  • Schedule an Appointment!
  • What to Bring to Your Appointment
  • What to Expect During Your Visit
  • Working with Your Insurance
  • Our Financial Policies
  • Privacy Policy and HIPAA
  • FAQs
  • Patient Forms

Contacts

San Antonio

607 Camden St
Suite 101
San Antonio, Texas 78215

Phone : 210-253-3426

Fax : 210-227-6951

Austin

7940 Shoal Creek Blvd
Suite 205
Austin, Texas 78757

Phone : 512-454-8378

Fax : 512-454-8375

Dallas

7515 Greenville Ave
Suite 600
Dallas, Texas 75231

Phone : 214-945-2521

Fax : 214-945-2524


Disclosures
Copyright © 2020 Texas Liver Institute All Rights Reserved
Texas Liver Institute